Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Elisabeth Puchhammer‐Stöckl, Alexander Zoufaly et al.|Genetics in Medicine|2021Cited by 138
Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” studyMathias Jachs, Péter Ferenci, Ivo Graziadei et al.|Alimentary Pharmacology & Therapeutics|2022Cited by 73
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Péter Ferenci, Marlene Panzer et al.|JHEP Reports|2023Cited by 27
Dissection of the NKG2C NK cell response against Puumala OrthohantavirusHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Svenja Hartenberger et al.|PLoS neglected tropical diseases|2021Cited by 9
NK cell receptor NKG2C deletion and HLA-E variants are risk factors for severe COVID-19Hannes Vietzen, Elisabeth Puchhammer‐Stöckl, Alexander Zoufaly et al.|Research Square (Research Square)|2020Cited by 8